Sage Journals: Discover world-class research

Retricted access

Case report

First published 2021-3

Larotrectinib followed by selitrectinib in a novel DCTN1–NTRK1 fusion undifferentiated pleomorphic sarcoma

Xue Na Goh, Michaela Su-Fern Seng, Amos Hong Pheng Loh [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2022-05

Redifferentiating Effect of Larotrectinib in NTRK -Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer

Lionel Groussin, Hélène Theodon, Laura Bessiene [...]

Thyroid®

Open access

Case report

First published 2025

Metastatic SQSTM1-NTRK1 fused non-small-cell lung cancer treated with larotrectinib and stereotactic radiosurgery resulting in durable complete response: a case report

Colton Betts, Ari Kassardjian, Arya Amini

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2020

Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries

Andrés F. Cardona, Oscar Arrieta, Alejandro Ruiz-Patiño [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Article commentary

First published 2020-12

Neurotrophic tyrosine kinase inhibitors: A review of implications for patients,clinicians and healthcare services

Andrew Walker

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025-2

Withdrawal pain following patients discontinuing Trk inhibitors

Alan Chin, Sheila Lindsay, Emily K Bergsland [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025-12

Late Recurrence of Spindle Cell Sarcoma in Association with TPM3::NTRK1 Fusion

Xenia Parisi, Anindita Ghosh, Wei-Lien Wang [...]

International Journal of Surgical Pathology

Retricted access

Research article

First published 2019-02

Patients with Advanced Thyroid Cancer Containing TRK Fusions May Benefit from Recently FDA-Approved Larotrectinib

Brian W. Kim

Clinical Thyroidology®

Open access

Case report

First published 2023

TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis

Arielle J. Medford, Lauren Oshry, Baris Boyraz [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2025

Identification of a novel PRUNE2::NTRK2 gene fusion in soft tissue sarcoma patients—friend or foe? Case series

Klaudia Bobak, Andrzej Tysarowski, Katarzyna A. Seliga [...]

Therapeutic Advances in Medical Oncology

Search results